Valuation: Biogen Inc.

Market Cap 32.03B 27.44B 25.67B 23.5B 44.1B 3,065B 44.69B 303B 118B 1,539B 120B 118B 5,092B P/E 2026 *
38.5x
P/E 2027 * 19x
Enterprise Value 36.97B 31.67B 29.63B 27.12B 50.9B 3,537B 51.57B 350B 137B 1,777B 139B 136B 5,877B EV / Sales 2026 *
3.54x
EV / Sales 2027 * 3.23x
Free-Float
85.8%
Yield 2026 *
-
Yield 2027 * -
1 day+1.13%
1 week+3.31%
Current month+6.81%
1 month+9.63%
3 months+11.88%
6 months+12.89%
Current year+23.18%
1 week 207.62
Extreme 207.62
222.15
1 month 199.4
Extreme 199.4
222.15
Current year 160.36
Extreme 160.3645
222.15
1 year 131.52
Extreme 131.52
222.15
3 years 110.04
Extreme 110.035
270.5
5 years 110.04
Extreme 110.035
350.45
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 28/10/2024
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
4/8/26 Sell

Director

-593 0.0004%
9/6/26 Free

Director

1,505 0.0010%
13/2/26 Free

Executive/Senior Manager

10,560 0.0072%
Change 5-day change 1-year change 3-year change Capi.($)
+1.13%+3.31%+55.61%-17.57% 32.03B
+0.90%+3.80%+41.49%-0.78% 83.28B
+8.86%+129.20%+435.14%+24.85% 57.94B
-1.69%+23.30%-22.30%-36.29% 57.77B
-1.46%+0.19%-2.06%+30.50% 51.75B
+1.74%+4.43%+12.37%+169.64% 49.35B
+0.46%+6.37%+50.29%+97.27% 25.91B
+1.19%+9.17%+2.97%+230.86% 22.74B
-0.30%+4.45%+58.29%+118.84% 16.87B
-5.74%+1.91%-1.42%+795.59% 16.08B
Average +0.51%+18.61%+63.04%+141.29% 41.37B
Weighted average by Cap. +1.16%+24.08%+77.34%+75.49%

Financials

2026 *2027 *
Net sales 10.44B 8.94B 8.37B 7.66B 14.38B 999B 14.57B 98.88B 38.56B 502B 39.21B 38.36B 1,660B 10.66B 9.13B 8.54B 7.82B 14.68B 1,020B 14.87B 101B 39.36B 512B 40.02B 39.15B 1,695B
Net income 953M 816M 764M 699M 1.31B 91.19B 1.33B 9.03B 3.52B 45.81B 3.58B 3.5B 152B 1.9B 1.63B 1.52B 1.39B 2.62B 182B 2.65B 17.98B 7.01B 91.29B 7.13B 6.98B 302B
Net Debt 4.94B 4.23B 3.96B 3.62B 6.8B 472B 6.89B 46.75B 18.23B 237B 18.54B 18.13B 785B 2.42B 2.07B 1.94B 1.78B 3.33B 232B 3.38B 22.92B 8.94B 116B 9.09B 8.89B 385B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
21/08/26 US$216.78 +1.13% 722,347
20/08/26 US$214.35 -3.25% 808,625
19/08/26 US$221.56 +4.24% 886,914
18/08/26 US$212.55 +1.63% 694,009
17/08/26 US$209.15 -0.32% 617,238
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
216.78USD
Average target price
235.57USD
Spread / Average Target
+8.67%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock